Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
| Image |  |
|---|---|
| Description | scientific article published on 24 December 2015 |
| Author/s |
author: Bonaventura Clotet Sala Linda Wittkop |
| Publication date | December 24, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |